Walmart Hit With Investor Suit Over DOJ Opioid Crisis Probe

By Hailey Konnath (January 20, 2021, 7:23 PM EST) -- Walmart shareholders on Wednesday accused the retail giant of withholding details about its alleged involvement in the opioid crisis, which resulted in a U.S. Department of Justice investigation, telling a Delaware federal court that the company's stock price tanked after the controversy came to light.

The Justice Department has accused Walmart — which operates about 5,000 pharmacies — of distributing and dispensing opioids in unlawful ways that fueled the opioid crisis. Meanwhile, the company has criticized the DOJ's professional conduct during the probe, saying it is "tainted by historical ethics violations."

In Wednesday's suit, named plaintiff Richard Stanton said the company misled investors...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!